Skip to main content
. 2019 Mar 28;18(4):e520–e523. doi: 10.18295/squmj.2018.18.04.015

Table 1.

Characteristics of patients with scalp seborrhoeic dermatitis after 10 weeks of treatment using a calcipotriol plus betamethasone dipropionate gel* (N = 32)

Variable Mean ± SD P value
Patients with complete clearance/marked improvement (n = 28) Patients with mild/moderate improvement (n = 4)
Age in years 35.2 ± 7.2 39.8 ± 2.1 0.224
Illness duration in months 11.5 ± 7.1 21.0 ± 11.5 0.032
Itching score 5.9 ± 1.2 8.0 ± 1.2 0.001
Discomfort score 5.3 ± 1.0 8.3 ± 1.0 <0.001

SD = standard deviation.

*

Daily Xamiol® gel (Leo Laboratories Ltd., Ballerup, Denmark).

Assessed by an attending dermatologist using the Physician Global Assessment Scale as either 0 (almost clear), 1 (mild), 2 (moderate), 3 (severe) or 4 (very severe).8

Self-reported by patients using a visual analogue scale on a scale of 0 (no symptoms) to 10 (most severe).